Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trial.

导出 OA

翻译打印收藏纠错

第一作者： Flor,Verghote

第一单位： Department of Radiotherapy-Oncology, Ghent University Hospital, Ghent, Belgium. flor.verghote@uzgent.be.;Department of Human structure and Repair, Ghent University, Ghent, Belgium. flor.verghote@uzgent.be.

作者： Flor,Verghote ^[1] ; Lindsay,Poppe ^[2] ; Sofie,Verbeke ^[3] ; Piet,Dirix ^[4] ; Maarten,Albersen ^[5] ; Gert,De Meerleer ^[6] ; Charlien,Berghen ^[6] ; Piet,Ost ^[7] ; Geert,Villeirs ^[8] ; Pieter,De Visschere ^[8] ; Kathia,De Man ^[9] ; Daan,De Maeseneer ^[10] ; Sylvie,Rottey ^[10] ; Charles,Van Praet ^[11] ; Karel,Decaestecker ^[11] ; Valérie,Fonteyne ^[2]

作者单位： Department of Radiotherapy-Oncology, Ghent University Hospital, Ghent, Belgium. flor.verghote@uzgent.be.;Department of Human structure and Repair, Ghent University, Ghent, Belgium. flor.verghote@uzgent.be. ^[1] Department of Radiotherapy-Oncology, Ghent University Hospital, Ghent, Belgium.;Department of Human structure and Repair, Ghent University, Ghent, Belgium. ^[2] Department of Pathology, Ghent University Hospital, Ghent, Belgium. ^[3] Department of Radiation-Oncology, Iridium Network, Antwerp, Belgium. ^[4] Department of Urology, University Hospitals Leuven, Leuven, Belgium. ^[5] Department of Radiotherapy-Oncology, University Hospitals Leuven, Leuven, Belgium. ^[6] Department of Human structure and Repair, Ghent University, Ghent, Belgium. ^[7] Department of Radiology, Ghent University Hospital, Ghent, Belgium. ^[8] Department of Nuclear Medicine, Ghent University Hospital, Ghent, Belgium. ^[9] Department of Medical Oncology, Ghent University Hospital, Ghent, Belgium. ^[10] Department of Human structure and Repair, Ghent University, Ghent, Belgium.;Department of Urology, Ghent University Hospital, Ghent, Belgium. ^[11]

关键词 18F-FDG-PET-CT Distant metastasis Immunotherapy Metastasis-directed therapy Muscle-invasive bladder cancer Neo-adjuvant chemotherapy Oligometastasis Overall survival Primary staging Stereotactic body radiation therapy